- Extraordinary profit on sale of shares amounting to EUR 214 million in the fourth quarter
- The funds will be applied to strengthen the balance sheet and to recognise risk provision
- Profit forecast reaffirmed for 2014 and 2015
The outstanding performance of the Swiss Life share in the past has meant that from a risk perspective, the weighting of this very large single life-insurance position has increased significantly within the Talanx portfolio. This risk will be mitigated as a result of the disposal. Swiss Life will continue to remain an important sales partner for the Talanx Group.
Talanx is primarily planning to use the released funds as a precautionary measure specifically to further strengthen the balance sheet and thereby take account of a potential sustained phase of low-interest rates, and to adjust valuations for underwriting positions. These measures position the Retail Germany Division to develop the business sustainably and successfully without being encumbered by risks even in a challenging market environment.
Talanx leaves its profits forecast for 2014 unchanged at Group net income of at least EUR 700 million. The profit target recently announced for 2015 and amounting to at least EUR 700 million also remains unchanged.